The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Analysis on triad therapy(三联疗法) in treatment of 35 patients with primary nephrotic syndrome
Author(s): 
Pages: 365-366
Year: Issue:  6
Journal: CHINESE JOURNAL OF INTEGRATED TRADITIONAL AND WESTERN MEDICINE IN INTENSIVE AND CRITICAL CARE

Keyword:  糖皮质激素脑明注射液黄芪注射液肾病综合征原发性中西医结合疗法;
Abstract: 目的:观察糖皮质激素、脑明注射液及黄芪注射液三联疗法治疗原发性肾病综合征的疗效.方法:将68例原发性肾病综合征患者随机分为糖皮质激素对照组33例和三联疗法治疗组35例,均为每日1次,4周为1个疗程,观察疗效及血液流变学指标的变化.结果:治疗组缓解率(65.7%)和总有效率(94.3%)均明显优于对照组(24.2%和66.7%),P均<0.05;治疗组复发率(6.1%)明显低于对照组(36.4%),P<0.05;治疗组血液流变学指标的改善明显优于对照组(P<0.05和P<0.01).结论:三联疗法治疗原发性肾病综合征疗效满意,能明显减少复发率.
Related Articles
loading...